Yersinia Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064493
  • May 2021
  • Biotechnology
  • 130 Pages
The Yersinia Diagnostics Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott, Gen-probe, Affymetrix Inc., Bio-Rad Laboratories, Hologic, Roche, BD, Danaher, Thermo Fisher Scientific Inc., bioMérieux SA
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Yersinia Diagnostics market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Yersinia Diagnostics market is expected to attain Pre COVID-19 levels by mid-2022.

Yersinia Diagnostics Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Yersinia Diagnostics market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Yersinia Diagnostics Market Competitive and Premeditated Analysis
In the Yersinia Diagnostics report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Yersinia Diagnostics research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Yersinia Diagnostics Market:
The Yersinia Diagnostics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott, Gen-probe, Affymetrix Inc., Bio-Rad Laboratories, Hologic, Roche, BD, Danaher, Thermo Fisher Scientific Inc., bioMérieux SA

The Yersinia Diagnostics market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Yersinia Diagnostics Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Yersinia Diagnostics market:
By Test
Stool Culture
ELISA
Radioimmunoassay
Tube Agglutination
CT Scan
Ultrasonography
Colonoscopy
Technique
PCR
DNA Probes
Monoclonal Antibodies
Immunoassay
IT
Others
End User
Hospital Laboratories
Public Health Laboratories
Commercial Laboratories

Regional Analysis of the Yersinia Diagnostics market:
The Yersinia Diagnostics market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Yersinia Diagnostics report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Yersinia Diagnostics market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Yersinia Diagnostics market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Yersinia Diagnostics market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Yersinia Diagnostics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Yersinia Diagnostics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Yersinia Diagnostics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Yersinia Diagnostics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Yersinia Diagnostics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott
  • Gen-probe
  • Affymetrix Inc.
  • Bio-Rad Laboratories
  • Hologic
  • Roche
  • BD
  • Danaher
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Stool Culture
  • ELISA
  • Radioimmunoassay
  • Tube Agglutination
  • CT Scan
  • Ultrasonography
  • Colonoscopy
  • Hospital Laboratories
  • Public Health Laboratories
  • Commercial Laboratories

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Yersinia Diagnostics Market Snapshot
          2.1.1. Global Yersinia Diagnostics Market By Test,2019
               2.1.1.1.Stool Culture
               2.1.1.2.ELISA
               2.1.1.3.Radioimmunoassay
               2.1.1.4.Tube Agglutination
               2.1.1.5.CT Scan
               2.1.1.6.Ultrasonography
               2.1.1.7.Colonoscopy
          2.1.2. Global Yersinia Diagnostics Market By End User,2019
               2.1.2.1.Hospital Laboratories
               2.1.2.2.Public Health Laboratories
               2.1.2.3.Commercial Laboratories
          2.1.3. Global Yersinia Diagnostics Market By End-use,2019
          2.1.4. Global Yersinia Diagnostics Market By Geography,2019

3. Global Yersinia Diagnostics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Yersinia Diagnostics Market Size (US$), By Test, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Test, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Test, 2020
     4.2. Global Yersinia Diagnostics Market Size (US$), By Test, 2018 – 2028

5. Global Yersinia Diagnostics Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Yersinia Diagnostics Market Size (US$), By End User, 2018 – 2028

6. Global Yersinia Diagnostics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Yersinia Diagnostics Market Size (US$), By End-use, 2018 – 2028

7. Global Yersinia Diagnostics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Yersinia Diagnostics Market Analysis, 2018 – 2028 
          7.2.1. North America Yersinia Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Yersinia Diagnostics Market Size (US$), By Test, 2018 – 2028
          7.2.3. North America Yersinia Diagnostics Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Yersinia Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Yersinia Diagnostics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Yersinia Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Yersinia Diagnostics Market Size (US$), By Test, 2018 – 2028
          7.3.3. Europe Yersinia Diagnostics Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Yersinia Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Yersinia Diagnostics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Yersinia Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Yersinia Diagnostics Market Size (US$), By Test, 2018 – 2028
          7.4.3. Asia Pacific Yersinia Diagnostics Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Yersinia Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Yersinia Diagnostics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Yersinia Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Yersinia Diagnostics Market Size (US$), By Test, 2018 – 2028
          7.5.3. Latin America Yersinia Diagnostics Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Yersinia Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Yersinia Diagnostics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Yersinia Diagnostics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Yersinia Diagnostics Market Size (US$), By Test, 2018 – 2028
          7.6.3. MEA Yersinia Diagnostics Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Yersinia Diagnostics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Yersinia Diagnostics Providers
        8.4.1 Abbott
                8.4.1.1 Business Description
                8.4.1.2 Abbott Geographic Operations
                8.4.1.3 Abbott Financial Information
                8.4.1.4 Abbott Product Positions/Portfolio
                8.4.1.5 Abbott Key Developments
        8.4.2 Gen-probe
                8.4.2.1 Business Description
                8.4.2.2 Gen-probe Geographic Operations
                8.4.2.3 Gen-probe Financial Information
                8.4.2.4 Gen-probe Product Positions/Portfolio
                8.4.2.5 Gen-probe Key Developments
        8.4.3 Affymetrix Inc.
                8.4.3.1 Business Description
                8.4.3.2 Affymetrix Inc. Geographic Operations
                8.4.3.3 Affymetrix Inc. Financial Information
                8.4.3.4 Affymetrix Inc. Product Positions/Portfolio
                8.4.3.5 Affymetrix Inc. Key Developments
        8.4.4 Bio-Rad Laboratories
                8.4.4.1 Business Description
                8.4.4.2 Bio-Rad Laboratories Geographic Operations
                8.4.4.3 Bio-Rad Laboratories Financial Information
                8.4.4.4 Bio-Rad Laboratories Product Positions/Portfolio
                8.4.4.5 Bio-Rad Laboratories Key Developments
        8.4.5 Hologic
                8.4.5.1 Business Description
                8.4.5.2 Hologic Geographic Operations
                8.4.5.3 Hologic Financial Information
                8.4.5.4 Hologic Product Positions/Portfolio
                8.4.5.5 Hologic Key Developments
        8.4.6 Roche
                8.4.6.1 Business Description
                8.4.6.2 Roche Geographic Operations
                8.4.6.3 Roche Financial Information
                8.4.6.4 Roche Product Positions/Portfolio
                8.4.6.5 Roche Key Developments
        8.4.7 BD
                8.4.7.1 Business Description
                8.4.7.2 BD Geographic Operations
                8.4.7.3 BD Financial Information
                8.4.7.4 BD Product Positions/Portfolio
                8.4.7.5 BD Key Developments
        8.4.8 Danaher
                8.4.8.1 Business Description
                8.4.8.2 Danaher Geographic Operations
                8.4.8.3 Danaher Financial Information
                8.4.8.4 Danaher Product Positions/Portfolio
                8.4.8.5 Danaher Key Developments
        8.4.9 Thermo Fisher Scientific Inc.
                8.4.9.1 Business Description
                8.4.9.2 Thermo Fisher Scientific Inc. Geographic Operations
                8.4.9.3 Thermo Fisher Scientific Inc. Financial Information
                8.4.9.4 Thermo Fisher Scientific Inc. Product Positions/Portfolio
                8.4.9.5 Thermo Fisher Scientific Inc. Key Developments
        8.4.10 bioMérieux SA
                8.4.10.1 Business Description
                8.4.10.2 bioMérieux SA Geographic Operations
                8.4.10.3 bioMérieux SA Financial Information
                8.4.10.4 bioMérieux SA Product Positions/Portfolio
                8.4.10.5 bioMérieux SA Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Yersinia Diagnostics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Yersinia Diagnostics Market Revenue, By Test, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Yersinia Diagnostics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Yersinia Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Yersinia Diagnostics Market Revenue, By Test, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Yersinia Diagnostics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Yersinia Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Yersinia Diagnostics Market Revenue, By Test, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Yersinia Diagnostics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Yersinia Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Yersinia Diagnostics Market Revenue, By Test, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Yersinia Diagnostics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Yersinia Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Yersinia Diagnostics Market Revenue, By Test, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Yersinia Diagnostics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Yersinia Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Yersinia Diagnostics: Market Segmentation 
FIG. 2 Global Yersinia Diagnostics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Yersinia Diagnostics Market, By Test, 2019 (US$ Mn) 
FIG. 5 Global Yersinia Diagnostics Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Yersinia Diagnostics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Yersinia Diagnostics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Yersinia Diagnostics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Yersinia Diagnostics Providers, 2019
FIG. 11 Global Yersinia Diagnostics Market Revenue Contribution, By Test, 2019 & 2028 (Value %) 
FIG. 12 Global Yersinia Diagnostics Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Yersinia Diagnostics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Yersinia Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Yersinia Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Yersinia Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Yersinia Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Yersinia Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Yersinia Diagnostics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Yersinia Diagnostics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Yersinia Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  North America Yersinia Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  North America Yersinia Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Europe Yersinia Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Yersinia Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Yersinia Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Yersinia Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Yersinia Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Yersinia Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Latin America Yersinia Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Yersinia Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Yersinia Diagnostics Market Value, By Country, 2018 – 2028
TABLE  MEA Yersinia Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Yersinia Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Yersinia Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gen-probe: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Affymetrix Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hologic: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BD: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  bioMérieux SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Yersinia Diagnostics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Yersinia Diagnostics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Yersinia Diagnostics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Yersinia Diagnostics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Yersinia Diagnostics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Yersinia Diagnostics Providers, 2016
FIG.  Global Yersinia Diagnostics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global ELISA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Radioimmunoassay Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tube Agglutination Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CT Scan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ultrasonography Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Colonoscopy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Yersinia Diagnostics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Public Health Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Commercial Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Yersinia Diagnostics Market Value, 2018 – 2028, (US$ Mn)